<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>Saad Salman Khan Lodhi</submitter><instrument_platform>Illumina HiSeq 2500</instrument_platform><instrument_platform>Standard molecular biology equipment (per Lexogen SENSE mRNA-seq kit protocol)</instrument_platform><instrument_platform>NanoDrop ND-1000 spectrophotometer; Agilent 2100 Bioanalyzer</instrument_platform><instrument_platform>Centrifuge (4 °C); ice/cold block</instrument_platform><study_type>RNA-seq of coding RNA</study_type><organism>Mus musculus</organism><species>Mus musculus</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-16537</full_dataset_link><description>Doxorubicin (DOX) is a widely used chemotherapeutic agent that can cause off-target gastrointestinal (GI) toxicity. This experiment profiles DOX-induced transcriptomic responses by RNA-seq in mouse colonoids (in vitro) across dose and time. Mouse colonoids were sampled at 24, 48 and 72 h after exposure to 0 (vehicle control), 0.1 or 10 µM DOX. The resulting RNA-seq data support analysis of GI toxicity mechanisms in an in vitro mouse intestinal model. A matched mouse colon (in vivo) RNA-seq dataset is deposited separately and will be cross-referenced via accession in the manuscript and/or the related accession field.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Nucleic Acid Extraction - Total RNA was extracted using the miRNeasy Mini Kit (Qiagen) following the manufacturer’s instructions. RNA quantity/purity were assessed by NanoDrop and RNA integrity was assessed by Agilent 2100 Bioanalyzer; samples with RIN > 6 and sufficient yield were used for library preparation.</sample_protocol><sample_protocol>Sequencing - Libraries were sequenced on an Illumina HiSeq 2500 platform using 100-bp paired-end reads (PE100), according to the manufacturer’s standard protocols.</sample_protocol><sample_protocol>Library Construction - mRNA sequencing libraries were prepared from total RNA using the Lexogen SENSE mRNA-seq library preparation kit, following the manufacturer’s instructions, including sample indexing for multiplexing.</sample_protocol><sample_protocol>Sample Collection - After exposure (24/48/72 h), Matrigel domes were dissolved on ice with cold PBS and colonoids were pelleted by centrifugation (200 × g, 5–10 min, 4 °C). Pellets were transferred to RNAlater (4 °C overnight) and stored at −80 °C until RNA extraction.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><pubmed_authors>Saad Salman Khan Lodhi</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq transcriptomics of doxorubicin (DOX) exposure in mouse colonoids (in vitro; 0, 0.1, 10 µM; 24, 48, 72 h), with raw paired-end FASTQ files</name><description>Doxorubicin (DOX) is a widely used chemotherapeutic agent that can cause off-target gastrointestinal (GI) toxicity. This experiment profiles DOX-induced transcriptomic responses by RNA-seq in mouse colonoids (in vitro) across dose and time. Mouse colonoids were sampled at 24, 48 and 72 h after exposure to 0 (vehicle control), 0.1 or 10 µM DOX. The resulting RNA-seq data support analysis of GI toxicity mechanisms in an in vitro mouse intestinal model. A matched mouse colon (in vivo) RNA-seq dataset is deposited separately and will be cross-referenced via accession in the manuscript and/or the related accession field.</description><dates><release>2026-02-28T00:00:00Z</release><modification>2026-02-28T02:02:24.175Z</modification><creation>2026-01-16T18:00:57.928Z</creation></dates><accession>E-MTAB-16537</accession><cross_references><ENA>ERP187664</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003738</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>